Cost‐Utility Analysis of Biomarker‐Based vs. <scp>USG</scp> + <scp>AFP</scp> Strategies for <scp>HCC</scp> Surveillance in Chronic Hepatitis B
ASAP every 6 months is the most cost-effective HCC surveillance strategy for patients with CHB and may be particularly suitable for resource-limited settings. Biomarker-based surveillance should be prioritised to improve outcomes and optimise resource use.
Authors
- Pimsiri Sripongpun (ORCID: https://orcid.org/0000-0003-0007-8214)
- Chanon Kongkamol (ORCID: https://orcid.org/0000-0003-3364-0664)
- Naichaya Chamroonkul (ORCID: https://orcid.org/0000-0002-5753-7939)
- Chayanis Kositamongkol (ORCID: https://orcid.org/0000-0001-7182-0733)
- Pochamana Phisalprapa (ORCID: https://orcid.org/0000-0003-1995-4405)
- Apichat Kaewdech (ORCID: https://orcid.org/0000-0002-4058-5977)
- Ratthanan Chantrakul (ORCID: https://orcid.org/0009-0001-7949-0211)
- Tanat Saeoui
Institutions
- Prince of Songkla University (TH)
- Siriraj Hospital (TH)
- Mahidol University (TH)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1111/apt.70386
- Citations
- 5
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.77